Induction of Primary Human T Cell Responses against Hepatitis C Virus-Derived Antigens NS3 or Core by Autologous Dendritic Cells Expressing Hepatitis C Virus Antigens: Potential for Vaccine and Immunotherapy-Reference-Cited by-同舟云学术

Induction of Primary Human T Cell Responses against Hepatitis C Virus-Derived Antigens NS3 or Core by Autologous Dendritic Cells Expressing Hepatitis C Virus Antigens: Potential for Vaccine and Immunotherapy

Published:2006-05-02 Issue:10 Volume:176 Page:6065-6075
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Li Wen,Krishnadas Deepa K.,Li Jie,Tyrrell D. Lorne J.,Agrawal Babita

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference40 articles.

1. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

2. EASL International Consensus Conference on Hepatitis C Paris, 26–28 February 1999

3. National Institutes of Health Consensus Development Conference on Management of Hepatitis C: 2002. June 10–12, 2002 , Bethesda, MD. Consensus statement.

4. Current therapy and new molecular approaches to antiviral treatment and prevention of hepatitis C

5. Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic strategies and promising vaccine for hepatitis C virus infection;Immunity, Inflammation and Disease;2023-08

2. Enhanced T Cell Responses Induced by a Necrotic Dendritic Cell Vaccine, Expressing HCV NS3;Frontiers in Microbiology;2020-11-24

3. Substitution of the CD81 Binding Site and β-Sandwich Area in E2 of HCV in Cambodia;Viruses;2020-05-16

4. Heterologous Immunity: Role in Natural and Vaccine-Induced Resistance to Infections;Frontiers in Immunology;2019-11-08

5. Virus-Like Particle Systems for Vaccine Development Against Viruses in the Flaviviridae Family;Vaccines;2019-09-20